Boots Healthcare Gains Access To U.S. Market Through Clearasil Buy
This article was originally published in The Rose Sheet
Executive Summary
Boots Healthcare International views its acquisition of the Clearasil acne prevention and treatment brand as a possible springboard for creating an OTC drug marketing presence in the U.S.
You may also be interested in...
Clearasil For Men Uses Anti-Acne Positioning To Enter Men’s Market
Clearasil for Men, the brand's first acne treatment line designed specifically for men, is expected to generate roughly $12 mil. at retail in its first year on shelves, according to the Boots Healthcare division
Clearasil For Men Uses Anti-Acne Positioning To Enter Men’s Market
Clearasil for Men, the brand's first acne treatment line designed specifically for men, is expected to generate roughly $12 mil. at retail in its first year on shelves, according to the Boots Healthcare division
Clearasil Ultra Treatment Bows With Neostrata AHA Technology
Boots will launchClearasil Ultra Treatment Cream in March formulated with patented alpha hydroxy acid technology from Neostrata